Rezultatele tratamentului hiperplaziei benigne a prostatei cu Prostamol®Uno (studiu clinic)

Ceban, E.; Tănase, A.; Ghicavîi, V.; Lupaşco, C.; Gorbatovschi, V.; Popov, M.

dc.contributor.author	Ceban, E.
dc.contributor.author	Tănase, A.
dc.contributor.author	Ghicavîi, V.
dc.contributor.author	Lupaşco, C.
dc.contributor.author	Gorbatovschi, V.
dc.contributor.author	Popov, M.
dc.date.accessioned	2022-04-20T12:41:41Z
dc.date.available	2022-04-20T12:41:41Z
dc.date.issued	2002
dc.identifier.citation	CEBAN, E., TĂNASE, A., GHICAVÎI, V., LUPAŞCO, C., et al. Rezultatele tratamentului hiperplaziei benigne a prostatei cu Prostamol®Uno (studiu clinic). In: Dializa și Transplant Renal din Republica Moldova: conferința 3-a de Urologie, conferința 2-a de Nefrologie: culegere de lucrări. Chișinău, 2002, pp. 53-56.
dc.identifier.uri	http://repository.usmf.md/handle/20.500.12710/20427
dc.description.abstract	Summary During 6 month 15 patients with BPH were treated with Prostamo®Uno, 320mg, daily. In this trial patients were assessed pre- and post- treatment with International Prostate Symptom Score (IPSS), the Quality of Life (QOL) and volume of residual urine appreciated ecographically. The analysis of our data shows decrease in IPSS score, QOL and volume of residual urine with in 53,4 %, 57,5% and 48,7% respectively. Prostamo®Uno is one of election drug in conservative treatment of BPH.	en_US
dc.language.iso	ro	en_US
dc.publisher	Societatea Urologilor din Republica Moldova	en_US
dc.relation.ispartof	Culegere de lucrări Conferința 3-a de Urologie, Conferința 2-a de Nefrologie: Dializa și Transplant Renal din Republica Moldova (30 - 31 octombie 2002)	en_US
dc.title	Rezultatele tratamentului hiperplaziei benigne a prostatei cu Prostamol®Uno (studiu clinic)	en_US
dc.type	Article	en_US